0 187

Cited 0 times in

Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2-locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study

DC Field Value Language
dc.date.accessioned2023-06-02T00:55:37Z-
dc.date.available2023-06-02T00:55:37Z-
dc.date.issued2022-09-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194533-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleGiredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2-locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorM. Martin Jimenez-
dc.contributor.googleauthorE. Lim-
dc.contributor.googleauthorM. Chavez Mac Gregor-
dc.contributor.googleauthorA. Bardia-
dc.contributor.googleauthorJ. Wu-
dc.contributor.googleauthorQ. Zhang-
dc.contributor.googleauthorZ. Nowecki-
dc.contributor.googleauthorF. Cruz-
dc.contributor.googleauthorR. Safin-
dc.contributor.googleauthorS-B. Kim-
dc.contributor.googleauthorC. Schem-
dc.contributor.googleauthorA. Montero-
dc.contributor.googleauthorS. Khan-
dc.contributor.googleauthorR. Bandyopadhyay-
dc.contributor.googleauthorM. Shivhare-
dc.contributor.googleauthorM. Patre-
dc.contributor.googleauthorJ. Martinalbo-
dc.contributor.googleauthorL. Roncoroni-
dc.contributor.googleauthorP.D. Pérez-Moreno-
dc.contributor.googleauthorJ. Sohn-
dc.identifier.doi10.1016/j.annonc.2022.07.250-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422021019-
dc.citation.volume33-
dc.citation.numberSupplement 7-
dc.citation.startPageS633-
dc.citation.endPageS634-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(Supplement 7) : S633-S634, 2022-09-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.